Led · Series C · Mar 2026

Moxie offers an integrated platform that combines EMR functionality with financial reporting, inventory management, and an AI assistant called “Maia.” Its software is purpose-built for medical spas and aesthetic clinics, giving independent providers the operational rigor typically found in large private-equity-backed chains. In March 2026 the company introduced “Scale Suite,” a new module that adds multi-provider infrastructure, margin intelligence, and AI-driven compliance alerts. Moxie’s system currently supports more than 700 aesthetic practices across the United States. The platform aims to streamline clinical workflows, enhance compliance, and improve financial performance for small-to-mid-sized practices. Management plans to deploy fresh capital to accelerate product rollout and further expand its AI capabilities. The company is headquartered in New York City and led by CEO Kamau Massey.

Led · Series C · Oct 2024

Founded in 2019, Farther offers an Intelligent Wealth Platform that integrates asset location, execution, data, risk management, personalized insights, and AI-driven tools for advisors. The platform provides access to private markets and supports a broad client base, from high-earning individuals and ultra-high-net-worth families (via Farther Family Office) to small businesses and institutions. Farther reported recruited assets of about $23 billion, encompassing both assets under management and expected assets from advisors transitioning to the platform. Since founding the company has raised over $272 million in total funding. The firm plans to use its Series D proceeds to scale platform capabilities, accelerate growth, and continue innovation to support advisors and clients. In 2025 Farther was recognized on the Inc. 5000 and Deloitte Technology Fast 500 lists and is a top recruiter in the RIA space.

Led · Equity · Jun 2023

Thinksurance is a Frankfurt, Germany–based InsurTech that provides a digital platform for commercial and industrial insurance consultations and policy processes. Its modular technology digitizes the entire consultation workflow from needs analysis to binding, enabling brokers, agents, direct sales and other distribution channels to deliver tailor-made insurance solutions quickly. The company also provides insurers and brokers with product digitalization and comprehensive data and analysis tools to support market-oriented and dynamic product and pricing strategies. Thinksurance has partnered with insurers including Allianz, Axa and Zurich, and more than 50,000 individual brokers and agents have used the platform to consult over 1.5 million customers. Led by CEO Florian Brokamp, the company raised $24M in funding to expand the platform to cover additional aspects of commercial insurance consultation and distribution. The round included lead investors Viewpoint Ventures, M‑Tech Capital and Venture Capital Fonds Segenia Capital, with participation from existing backers Eight Roads Ventures and Columbia Lake Partners. Thinksurance operates a B2B insurance distribution platform that helps digitalize the commercial insurance distribution process by connecting insurers, brokers and businesses. The company works with all major insurance houses and more than 20,000 brokers. It intends to use new funding to scale operations, expand its existing platform and grow into new international markets. Thinksurance raised €13M in a Series B led by Eight Roads Ventures. Founded in 2016 by Florian Brokamp and Christopher Leifeld, the company is based in Frankfurt, Germany. Previous investors include Police Direct, the Hoesch Group, the German Startups Group, Nikolai Dördrechter and Christian Vollmann.

Participated · Series A · Jul 2020

Orpyx builds the Sensory Insole system that integrates multi-modal sensor technology with a dedicated team of specialized nurses to enable continuous remote monitoring of plantar pressure, temperature, activity, and adherence. The system is used to prevent diabetic foot ulcers (DFU) and lower-limb amputations by empowering patients with personalized remote care. Orpyx partners with U.S. health plans and organizations such as the Veterans Health Administration to deploy its solution. The company announced an additional $20 million in growth capital to accelerate its commercial efforts and expand patient access. Orpyx positions itself as a leader in DFU and amputation prevention and emphasizes improving mobility and healthspan for people with diabetes and peripheral neuropathy. The company lists New York and Calgary, Alberta in its announcement and focuses on scaling clinical and payer relationships. Orpyx Medical Technologies develops the Orpyx SI Sensory Insoles, a sensory insole with telemedicine capabilities that delivers real-world plantar pressure feedback and real-time analytics to help prevent diabetic foot and neuropathy-related ulcers. The technology also provides clinical-grade plantar pressure data for researchers in sports medicine, therapeutic applications and footwear design. Led by Dr. Breanne Everett, CEO and co‑inventor, the company plans to use new funding to expand North American commercialization and to broaden and accelerate technology development. Orpyx is based in Calgary, Canada. The company closed a $7.6M Series A round in 2020, bringing total funding since inception to $18.5M.